Chinese herbal medicines for treating pre-eclampsia

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2006, Pages

  Li, Wenjuan ^a   Tang, Liulin ^a   Wu, Taixiang ^b   Zhang, Jing ^a   Liu, Guan J ^b   Zhou, Lingling ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898702480     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005126.pub2     Document Type: Review

References (90)

1. Cao W, Yuan M, Zhu A. Observation on effect of milkvetch injection in treating 401 patients with PIH. Shangdong Medical Journal 2002;42(20):50.
2. Chen S. Clinical observation on integrated treatment of Ligustrazin injection and western medicine for PIH. Fujian Journal of TCM 2002;33(5):11-2.
3. Chen D, Zhao Y, She R, Wen L, Su C, Huang Y, et al. Comparative study on effect of ligustrazine and magnesium sulfate on patients with pregnancy induced hypertension syndrome. Chinese Journal of Integrated Traditional and Western Medicine 2003;23(3):185-7.
4. Chen D, Zhao Y, She R, Wen L, Su C, Huang Y, et al. Effect of salvia miltiorrhiza, ligustrazine and magnesium sulfate on outcomes of patients with pregnancy-induced hypertension. Chinese Journal of Perinatal Medicine 2003;6(5):259-62.
5. Chen D, Zhao Y, She R, Wen L, Su C, Huang Y, et al. Mechanism investigation and primary observation on clinical effect of Salvia miltiorrhiza in treating PIH. China Journal of Modern Medicine 2003;13(18):114-5.
6. Fang J. Integrated treatment of TCM and western medicine for HSP and variety of plasma Hcy and NO. Journal of Heman Medical College for Staff and Workers 2006;18(4):308-10.
7. Fu H. Analysis of clinical efficacy of Salvia Miltiorrhizae on PIH. Zhejiang Journal of Clinical Medicine 2008;10(1):76.
8. Guo TL, Liu C, Liu P. Clinical observation on treatment of gestational hypertension syndrome with angelica and paeonia powder. Chinese Journal of Integrated Traditional and Western Medicine 1986;6(12):14-6.
9. Hong M. Observation on effect of Danshen in treating PIH. Henan Journal of Practical Nervous Diseases 2002;5(2):66.
10. Hou W, Zhang X, Zheng G, Li H. Clinical observation on Ligustrazin in treating PIH. Chinese Journal of Integrated Traditional and Western Medicine 2002;22(8):617.
11. Hu Z, Fang M, Wu L, Wang Y, Chen L, Li J. Study of ligustrazine combined with bitter salt on pregnancy induced hypertension syndrome. Modern Journal of Integrated Traditional Chinese and Western Medicine 2004;13(11):1409-12.
12. Huang Y, Ye D, Ma T. The effects of 3,4-dihydroxyacetophynone on the activity of nitric oxide synthenase in placental vascular endothelial cells and smooth muscle cells and on the level of endothelin-1in plasma from pregnancy-induced hypertension patients. Chinese Journal of Obstetrics and Gynecology 1996;31(11):667-9.
13. Huang Y, Ye D, Ma T, Wu X. The influence of 3,4-dihydroxyacetophynone on the levels of atrial natriuretic polypeptide, cGMP and cAMP in maternal and fetal plasma from PIH-patients. Acta Universitatis Medicines Tongji 1998;27(6):470-3.
14. Kuang B. Clinical observation on the treatment of 37 cases of gravidic HBP syndrome with combination of traditional Chinese and Western medicine. Guiding Journal of TCM 2005;11(7):34-5;49.
15. Li Z. Clinical analysis of pregnant hypertension treated by integration of Chinese and western medicine. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease 2003;1(7):399-401.
16. Liao YT, Wu XQ, Peng J. Effective observation on Ligustrazine in treating 65 cases with PIH. Journal of Qiaihar Medical College 2004;25(4):379-80.
17. Liu L, Zhang Y, Ma B. Clinical research on TCM in treating PIH. Chinese Journal of Information on Traditional Chinese Medicine 2000;17(2):48-9.
18. Liu Z, Wu C. Effect of Salvia Miltiorrhizae in treating moderate PIH. Occupation and Health 2004;20(6):139-40.
19. Luan F, Yin H, Dong P. Clinical observation on Mailuoning in treating 46 patients with PIH. Chinese Journal of Integrated Traditional and Western Medicine 1995;15(3):153-5.
20. Man D, Feng B, Jiang G. Cohort study of Milkvetch Root combined with vitamin E in treating mild PIH. Lishizhen Medicine and Materia Medica Research 2004;15(4):231-1.
21. Meng H, Guo J, Wang X, Yang L, Liang F. Clinical observation on effect of salvia miltiorrhiza injection combined with ligustrazine in treating 50 patients with moderate or severe pregnancy-induced hypertension syndrome. Hebei Journal of Traditional Chinese Medicine 2003;25(6):409-10.
22. Qian X, Huang Y, Wu S. Clinical analysis of ligustrazine in treating PIH. Chinese Journal of Integrated Traditional and Western Medicine 1991;11(9):533-4.
23. Shen D, Lin Q, Zhou H, Jia S, Pan J, Guo Q. Huoxuehuayujiejin preparation to treat PIH. Shangdong Medical Journal 1984;7(9):552-3.
24. Su C, Wang D. Research on effect of little dose of rhubarb in treating PIH. Clinical Journal of Anhui Traditional Chinese Medicine 2002;14(2):86-7.
25. Sun Y, Ma T, Wu X. Primary research on effect and mechanism of 3,4-dihydroxyacetophynone in treating PIH. Journal of Practical Obstetrics and Gynecology 1991;7(3):141-3.
26. Tan Z, Li K, Wang Y. Clinical observation of integrated treatment of TCM and western medicine for hypertensive syndrome of pregnancy. Hunan Guiding Journal of Traditional Chinese Medicine Pharmacology 2000;6(2):21-2.
27. Tang S, Liu Z, Liu Y, Ge C. Clinical observation on ligustrazine in treating 38 patients with PIH. Lishizhen Medicine and Materia Medica Research 1998;9(5):393-4.
28. Wang B, Luo X, Wu R. Effect analysis of the Quyu soup in treating PIH. New Journal of Traditional Chinese Medicine 1997;29(8):15-7.
29. Wang L. The soup of Zicaojueming to treat 60 patients with PIH. Zhejiang Journal of Traditional Chinese Medicine 1998;33(7):303.
30. Wang Z, Song H. Clinical observation on therapeutical effect of prepared rhubarb in treating pregnancy induced hypertension. Chinese Journal of Integrated Traditional and Western Medicine 1999;19(12):725-7.
31. Wang Z, Song H. Primary observation on effect of rhubarb in treating PIH. China Journal of Traditional Chinese Medicine and Pharmacy 2000;15(2):69-70.
32. Wang S, Wei S. Protective effect of Salvia Miltiorrhizae injection on renal function in PIH patients. Journal of Sun Yatsen University (Medical Sciences) 2004;25(3S):136-8.
33. Wang W, Qing A. Effective observation of TCM combined with western medicine in treating PIH. Lishizhen Medicine and Materia Medica Research 2004;15(9):626.
34. Wang Z, Shao C, Song H. Influence of prepared rhubarb on TH1 and TH2 cytokine in PIH patients. Shangdong Journal of Traditional Chinese Medicine 2005;24(10):619-21.
35. Wang Q, Shen Z, Zhou C, Xiao H, Liu S, Hu Y, et al. Clinical research and investigation of Danshen pill in treating PIH. Chinese Traditional Patent Medicine 2006;28(2):212-4.
36. Wei Y, Shi X, Wang C. Clinical observation of intrauterine growth retardation of fetus treated mainly by 'Granule for pregnancy hypertension'. Shanghai Journal of Traditional Chinese 2000;34(5):36-7.
37. Wei S, Hu S, Tian N. Clinical observation on therapeutic effect of the soup of decreasing viscosity and eliminating thromboembolism in treating PIH. Chinese Journal of Information on Traditional Chinese Medicine 2002;9(7):56.
38. Wei L. Clinical application of Danshen injection in treating PIH. Chinese Community doctors 2004;20(258):36.
39. Wu S, Qian X, Huang Y, Huang Q. Effect investigation of ligustrazine in treating PIH -monitoring of bulbar conjunctiva microcirculation. Journal of Chinese Microcirculation 1993;1(4):193-4.
40. Xu M, Qian Z. Clinical analysis of integrated treatment of TCM and western medicine for 63 patients with PIH. Shanghai Journal of Traditional Chinese Medicine 1984;18(3):14-7.
41. Yang Z, Jiao Z, Nou H, Xu C. Clinical observation on integrated treatment of Mailuoning injection and western medicine for PIH. Chinese Journal of Integrated Traditional and Western Medicine 2001;21(7):536-7.
42. Yang HL. Aspirin combined with ligustrazine in treating 42 patients with PIH. Shangdong Medical Journal 2006;46(14):34.
43. Wang R, You Z, Fu L. Research on effect of Buqihuoxue method for the level of TXB2 and 6-K-PGF1 in patients with PIH. Chinese Journal of Traditional Medical Science and Technology 1999;6(4):250-1.
44. Wang R, You Z, Fu L. Research on the effect of Buqihuoxue method for ability of changing shape of RBC in patients with PIH. Chinese Journal of Traditional Medical Science and Technology 1999;6(4):251-2.
45. You Z, Wang R, Fu L. Research on effect of Buqihuoxue method for the level of ET in the patients with PIH. Chinese Journal of Traditional Medical Science and Technology 1999;6(4):247-9.
46. You Z, Wang R, Fu L. Research on effect of Buqihuoxue method for the level of NO in PIH. Chinese Journal of Traditional Medical Science and Technology 1999;6(4):249-50.
47. Zhang C, Yu L, Lv S, Guan S. Clinical research of ligustrazine in treating patients with PIH. Chinese Journal of Obstetrics and Gynecology 1993;28(4):232-3.
48. Zhang H. Integrated treatment of TCM and western medicine in treating PIH. Chinese Journal of Rural Medicine and Pharmacy 2002;9(9):18-9.
49. Zhang X, Li J. Clinical observation of TCM combined with western medicine in treating PIH. Chinese Community Doctors 2005;7(114):59-60.
50. Zhang Y, You Z, Wu Z, Wei H, Luo J. Research of Yiqihuayu intervention on serum IGT-1, IGFBP-1 of PIH patients. Journal of Emergency in Traditional Chinese Medicine 2007;16(6):652-3.
51. Zhang Y, You Z, Wu Z, Zhang W. Influence of Yiqihuayu intervention on placenta tissue HIF-1a of PIH patients. Journal of Emergency in Traditional Chinese Medicine 2006;15(5):485-6.
52. Zhao Y, Wen J, Zhao S, Lai Y. Study of puerarin on outcomes of patients with hypertensive disorder complicating pregnancy. Chinese Journal of Practical Gynecology and Obstetrics 2005;21(3):158-60.
53. Zhong S, Yuan Y. Clinical research on Dangui mixture in treating patients with PIH and IUGR. Shangdong Journal of Traditional Chinese Medicine 2002;21(3):141-2.
54. Zhu Y. Clinical research on Ligustrazin in treating PIH. Lishizhen Medicine and Materia Medica Research 2002;13(5):293-4.
55. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD002252.pub2]
56. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG Technical Bulletin 1996;219:1-8.
57. Anonymous. Hypertension in pregnancy. American College of Obstetricians and Gynecologists Technical Bulletin. Washington, DC: American College of Obstetricians and Gynecologists, 1996.
58. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al. The detection, investigation, and management of hypertension in pregnancy: full consensus statement. Australian and New Zealand Journal of Obstetrics and Gynaecology 2000;40(2):139-55.
59. Brown MA, Lindheimer MD, De Swiet M, Van Assche A, Moutquin J. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertension in Pregnancy 2001;20(1):ix-xiv.
60. Duley L, Gülmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD000025]
61. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001449.pub2]
62. Duley L, Henderson-Smart DL, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD000492.pub2]
63. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
64. Gates S. Methodological guidelines. In: The Editorial Team. Pregnancy and Childbirth Group. About The Cochrane Collaboration (Collaborative Review Groups (CRGs)) 2005, Issue 2.
65. Geng XF, Sun XL, Wang HG, Xu LZ, Zhang NS, Li GZ. Experimental and clinical research on flavone of ginkgo leaf in decreasing blood pressure. China Journal of Chinese Materia Medica 2002;27(8):606-8.
66. Gou W, Fang J. The prediction and progress of hypertension in pregnancy. Chinese Journal of Practical Gynecology and Obstetrics 2004;20(10):581-3.
67. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
68. House of Lords Select Committee. Science and Technology - Sixth Report: complementary and alternative medicine. http://www.publications.parliament.uk/pa/ld199900/ldselect/ldsctech/123/12303.htm#a3 (accessed 2004).
69. Huang B, Wang X, Liu G. Danggui. In: Wang Y, Deng W, Xue C editor(s). Pharmacology and applications of Chinese materia medica. 2nd Edition. Beijing: People's Medical Publishing House, 1998:439-49.
70. Huang WZ, Zhang BY, Wang XJ. The effect of Danggui on plasma ET in hypertension patients. Journal of Mathematical Medicine 1998;11(4):367-8.
71. Industry institution of Beijing pharmacy. Research on effective composition of Ligustrazine. Chinese Medical Journal 1977;57:420-3.
72. Lampert N, Xu Y. Chinese herbal nephropathy. Lancet 2002;359(9308):796-7.
73. Li YK, Jiang MY. Pharmacology of Chinese traditional medicine. Beijing: Chinese CTM press, 1992.
74. Liu SY, Xu YY, Zhu JY. The effects of Salvia miltiorrhizae Bge and Ligustrazine on thromboxane A2 and prostacyclin in pregnancy induced hypertension. Chinese Journal of Obstetrics and Gynecology 1994;29(11):648-50, 697.
75. Liu C. Danshen. In: Wang Y, Deng W, Xue C editor(s). Pharmacology and applications of Chinese materia medica. 2nd Edition. Beijing: People's Medical Publishing House, 1998:190-218.
76. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001;358(9292):1515-6.
77. Meher S, Duley L, Prevention of Pre-eclampsia Cochrane Review authors. Interventions for preventing pre-eclampsia and its consequences: generic protocol. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005301]
78. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. Annals of Internal Medicine 2001;134(8):657-62.
79. Anonymous. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynecology 2000;183(1):1-22.
80. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New England Journal of Medicine 2000;342(23):1686-92.
81. Qu YH, Li SL, Xu W. Effects of taurine on brain ET and CGRP in spontaneously hypertensive rats. Journal of Zhengzhou University (Medical Sciences) 2003;38(4):541-2.
82. Ran JL, Du JR, Zeng QZ, Qian ZM. Advance in studies on chemical components, pharmacological effect and clinical application of Leonurus japonicus. Chinese Traditional and Herbal Durgs 2003;34(11):15-9.
83. Steyn DW, Steyn P. Low-dose dopamine for women with severe pre-eclampsia. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD003515.pub2]
84. Sun X. Fuling. In: Wang Y, Deng W, Xue C editor(s). Pharmacology and applications of Chinese materia medica. 2nd Edition. Beijing: People's Medical Publishing House, 1998:803-7.
85. Tao JX, Shao WZ, Zhang Y. The effect of Ligustrazine and glonoin on prostacyclin secreted by human vascular endotheliocyte in vitro. Chinese Journal of Neurosurgery 1987;3:223.
86. Wang J. Chuan Xiong. Pharmacology and applications of Chinese materia medica. Beijing: People's Medical Publishing House, 1998:112-9.
87. Wu T, Li Y, Bian Z, Liu G, Moher D. Randomized trials published in some Chinese journals: how many are randomized. Trials 2009;10:46. [DOI: 10.1186/1745-6215-10-46]
88. Yang WD, Zhu HL, Zhao BL. The effect of Danshen on clearance of oxygen-derived free radicals. Chinese Pharmacological Bulletin 1990;5(2):118-20.
89. Zhang HM, Zhuang QQ, Li CZ. The effect of Salvia miltiorrhiza ketone and sulfonic natrium on the activity of Mg-ATP enzyme activated by platelet actin. Journal of FuDan University (Medical Science) 1988;15:289.
90. Zhang C, Ma G, Yv L, Guan S. The research of the complex of Danshen and Vit E for the prevention of the PIH. Chinese Journal of Obstetrics and Gynecology 1997;9:356-8.